Sarah Farooq

758 total citations
10 papers, 84 citations indexed

About

Sarah Farooq is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Sarah Farooq has authored 10 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Reproductive Medicine and 2 papers in Surgery. Recurrent topics in Sarah Farooq's work include Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (2 papers) and Genetic factors in colorectal cancer (2 papers). Sarah Farooq is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (2 papers) and Genetic factors in colorectal cancer (2 papers). Sarah Farooq collaborates with scholars based in United States, Saudi Arabia and India. Sarah Farooq's co-authors include Joyce F. Liu, Ursula A. Matulonis, William T. Barry, Alexi A. Wright, Kamath Sriganesh, Mary K. Buss, Deborah K. Armstrong, Susan Schumer, Elizabeth M. Swisher and Beverly Moy and has published in prestigious journals such as Journal of Clinical Oncology, Physiology & Behavior and BMC Genomics.

In The Last Decade

Sarah Farooq

10 papers receiving 82 citations

Peers

Sarah Farooq

ONCOL

PRM

Heather MacGregor Canada

Eugenia Ortega Spain

Amit Agarwal India

Marina Sahade Brazil

Yuemei Wang United States

Nathalie Bonnin France

Angela Jain United States

E. Salinas United States

Youstina Hanna Canada

Constantina Mateoiu Sweden

Heather MacGregor Canada

Sarah Farooq

103 ×1.6

ONCOL

8 ×0.3

15 ×0.6

PRM

20 ×1.1

6 ×0.5

Citations per year, relative to Sarah Farooq Sarah Farooq (= 1×) peers Heather MacGregor

Countries citing papers authored by Sarah Farooq

Since Specialization

Citations

This map shows the geographic impact of Sarah Farooq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Farooq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Farooq more than expected).

Fields of papers citing papers by Sarah Farooq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Farooq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Farooq. The network helps show where Sarah Farooq may publish in the future.

Co-authorship network of co-authors of Sarah Farooq

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Farooq. A scholar is included among the top collaborators of Sarah Farooq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Farooq. Sarah Farooq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Farooq, Sarah, et al.. (2024). Bihemispheric IDH-Wildtype Glioblastoma with Unilateral FGFR3-TACC3 Fusion in Patient with Breast Cancer History: A Case Report and Literature Review. American Journal of Clinical Pathology. 162(Supplement_1). S133–S134. 1 indexed citations

Inglis, Angela, et al.. (2021). Strain-based and sex-biased differences in adrenal and pancreatic gene expression between KK/HlJ and C57BL/6 J mice. BMC Genomics. 22(1). 180–180. 1 indexed citations

Inglis, Angela, et al.. (2019). Strain and sex-based glucocentric & behavioral differences between KK/HlJ and C57BL/6J mice. Physiology & Behavior. 210. 112646–112646. 7 indexed citations

Luo, Wenjie, Mark A. Hoffman, Neil S. Horowitz, et al.. (2018). Phase II study of pembrolizumab (pembro) combined with pegylated liposomal doxorubicin (PLD) for recurrent platinum-resistant ovarian, fallopian tube or peritoneal cancer. Gynecologic Oncology. 149. 24–24. 8 indexed citations

Konstantinopoulos, Panagiotis A., Carolyn Krasner, Mary K. Buss, et al.. (2018). Phase II, two-stage study of avelumab in patients with microsatellite stable (MSS), microsatellite instable (MSI) and polymerase epsilon (POLE) mutated recurrent or persistent endometrial cancer. Gynecologic Oncology. 149. 24–25. 5 indexed citations

Liu, Joyce F., William T. Barry, Robert M. Wenham, et al.. (2018). A phase 2 biomarker trial of combination cediranib and olaparib in relapsed platinum (plat) sensitive and plat resistant ovarian cancer (ovca).. Journal of Clinical Oncology. 36(15_suppl). 5519–5519. 13 indexed citations

Konstantinopoulos, Panagiotis A., Joyce F. Liu, William T. Barry, et al.. (2017). Phase 2, two-group, two-stage, open-label study of avelumab in patients with microsatellite stable, microsatellite instable and POLE-mutated recurrent or persistent endometrial cancer.. Journal of Clinical Oncology. 35(15_suppl). TPS5615–TPS5615. 6 indexed citations

Liu, Joyce F., William T. Barry, Michael J. Birrer, et al.. (2017). Overall survival and updated progression-free survival results from a randomized phase 2 trial comparing the combination of olaparib and cediranib against olaparib alone in recurrent platinum-sensitive ovarian cancer.. Journal of Clinical Oncology. 35(15_suppl). 5535–5535. 13 indexed citations

Freedman, Rachel A., Rebecca Gelman, Michelle Melisko, et al.. (2017). TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).. Journal of Clinical Oncology. 35(15_suppl). 1005–1005. 28 indexed citations

10.

Sriganesh, Kamath, Sarah Farooq, & K. Byrappa. (2014). Temporomandibular Joint Dislocation During Tracheal Intubation in a Patient With Sjogren Syndrome. Journal of Neurosurgical Anesthesiology. 27(1). 82–83. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact